Paranovus Entertainment Technology Ltd.(PAVS)

Medical - Pharmaceuticals · New York, NY

$3.82+0.05 (+1.33%)

Delayed quote: Oct 6, 2026, 3:42 PM EDT

Paranovus Entertainment Technology (PAVS) Price/Sales Ratio: History & Chart | TGMCharts

PS Ratio: N/A

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T19:48:51.244Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:48:51.244Z.

Quote observation: 2026-10-06T19:42:25.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 3,273,171
TTM revenue · period ending 2026-03-31: N/A

FMP input reference: 2a0cb01cc31f7f7a1ab27ea5f4e27b2bab80fdffd2dde3b1d08905865647984d

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

PAVS PS Ratio Metrics

PS RATIO

N/A

PAVS Competitors' PS Ratio

PAVS

Paranovus Entertainment Technology Ltd.

Current

Market Cap

$3.27M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBAI

MBody AI Ltd.

vs PAVS

Market Cap

$3.21M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AEMD

Aethlon Medical, Inc.

vs PAVS

Market Cap

$3.26M

PS Ratio

N/A

TTM Avg

69.25

3Y Avg

700.44

5Y Avg

2108.35

REVB

Revelation Biosciences, Inc.

vs PAVS

Market Cap

$2.93M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ICCM

IceCure Medical Ltd

vs PAVS

Market Cap

$3.12M

PS Ratio

0.79

TTM Avg

8.88

3Y Avg

13.52

5Y Avg

16.08

MBIO

Mustang Bio, Inc.

vs PAVS

Market Cap

$3.49M

PS Ratio

N/A

TTM Avg

141717.15

3Y Avg

141717.15

5Y Avg

141717.15

NXL

Nexalin Technology, Inc.

vs PAVS

Market Cap

$3.35M

PS Ratio

15.41

TTM Avg

54.87

3Y Avg

78.32

5Y Avg

59.55

MLEC

Moolec Science S.A.

vs PAVS

Market Cap

$3.46M

PS Ratio

N/A

TTM Avg

2.56

3Y Avg

108.40

5Y Avg

108.40

BRTX

BioRestorative Therapies, Inc.

vs PAVS

Market Cap

$3.11M

PS Ratio

8.68

TTM Avg

15.52

3Y Avg

50.28

5Y Avg

84.84

EOCN

Eocene Ltd.

vs PAVS

Market Cap

$3.54M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Paranovus Entertainment Technology Ltd. (PAVS)	$3.27M	N/A	N/A	N/A	N/A
MBody AI Ltd. (MBAI)vs ›	$3.21M	N/A	N/A	N/A	N/A
Aethlon Medical, Inc. (AEMD)vs ›	$3.26M	N/A	69.25	700.44	2108.35
Revelation Biosciences, Inc. (REVB)vs ›	$2.93M	N/A	N/A	N/A	N/A
IceCure Medical Ltd (ICCM)vs ›	$3.12M	0.79	8.88	13.52	16.08
Mustang Bio, Inc. (MBIO)vs ›	$3.49M	N/A	141717.15	141717.15	141717.15
Nexalin Technology, Inc. (NXL)vs ›	$3.35M	15.41	54.87	78.32	59.55
Moolec Science S.A. (MLEC)vs ›	$3.46M	N/A	2.56	108.40	108.40
BioRestorative Therapies, Inc. (BRTX)vs ›	$3.11M	8.68	15.52	50.28	84.84
Eocene Ltd. (EOCN)vs ›	$3.54M	N/A	N/A	N/A	N/A

How this was calculated

Half-year reporter: no trailing two-half-year basis, because the half-year figures cannot be checked against the annual report: the newest completed fiscal year's annual revenue and net income are both below 25 million, too small to compare.

The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.

These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio: N/A

PAVS PS Ratio Metrics

PAVS Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

Related Metrics